Mindfulness Stress Reduction Reduces Loneliness in Elderly

This article originally appeared here.
Share this content:
Mindfulness Stress Reduction Reduces Loneliness in Elderly
Mindfulness Stress Reduction Reduces Loneliness in Elderly

(HealthDay News) -- An eight-week mindfulness-based stress reduction (MBSR) program reduces loneliness compared with a wait-list control, and also reduces pro-inflammatory gene expression in older adults, according to a study published online July 20 in Brain, Behavior, and Immunity.

J. David Creswell, from Carnegie Mellon University in Pittsburgh, and colleagues examined loneliness and loneliness-related pro-inflammatory gene expression in a cohort of 40 older adults, aged 55 to 85 years, randomized to an eight-week MBSR program or to a wait-list control group.

The researchers found that the MBSR program correlated with reduced loneliness, compared to small increases in loneliness in the control group (treatment condition × time interaction P = 0.008). There was a correlation between reported loneliness and upregulated pro-inflammatory NF-κB-related gene expression in circulating leukocytes at baseline, and this gene expression profile was downregulated in the MBSR group post-treatment. There was a trend for MBSR to reduce C-reactive protein (treatment condition × time interaction P = 0.075).

"This study provides a promising initial indication that the eight-week MBSR program may reduce perceptions of loneliness in older adults, which is a well-known risk factor for morbidity and mortality in aging populations," the authors write. "MBSR can significantly downregulate the expression of inflammation-related genes in parallel with reductions in loneliness."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs